ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04217	Necroptosis	5/24	178/7206	0.000252294527115
ko05152	Tuberculosis	5/24	187/7206	0.000317341052771
ko04115	p53 signaling pathway	3/24	74/7206	0.00180213999359
ko05130	Pathogenic Escherichia coli infection	3/24	77/7206	0.00202033410576
ko05161	Hepatitis B	4/24	173/7206	0.00234142195891
ko05132	Salmonella infection	3/24	98/7206	0.00401264474188
ko00512	Mucin type O-glycan biosynthesis	2/24	29/7206	0.00408589399901
ko04666	Fc gamma R-mediated phagocytosis	3/24	122/7206	0.00739221085526
ko04215	Apoptosis - multiple species	2/24	47/7206	0.0104892106965
ko04621	NOD-like receptor signaling pathway	3/24	157/7206	0.0146801322989
ko04932	Non-alcoholic fatty liver disease (NAFLD)	3/24	182/7206	0.0217175925665
ko05168	Herpes simplex infection	3/24	182/7206	0.0217175925665
ko05167	Kaposi's sarcoma-associated herpesvirus infection	3/24	191/7206	0.0246351929744
ko05014	Amyotrophic lateral sclerosis (ALS)	2/24	74/7206	0.0248177462142
ko04144	Endocytosis	4/24	342/7206	0.0249554306481
ko01524	Platinum drug resistance	2/24	76/7206	0.0260815144143
ko05131	Shigellosis	2/24	82/7206	0.0300269300527
ko03018	RNA degradation	2/24	84/7206	0.0313922175672
ko05323	Rheumatoid arthritis	2/24	89/7206	0.0349117238807
ko04064	NF-kappa B signaling pathway	2/24	96/7206	0.0400855037608
ko04650	Natural killer cell mediated cytotoxicity	2/24	97/7206	0.0408473396355
ko05100	Bacterial invasion of epithelial cells	2/24	99/7206	0.0423876301852
ko04620	Toll-like receptor signaling pathway	2/24	100/7206	0.0431660010429